Article Details
Retrieved on: 2024-10-14 14:46:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Currently only Inmazeb, a combination of three monoclonal antibodies, and Ebanga, a single monoclonal antibody, are FDA-approved to treat EBOV ...
Article found on: nocamels.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here